Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lonza GroupLZAGY +0.98%84 EV-to-OCF is 27.71 as of Sep. 22, 2026, which is 12% below its 10-year median of 31.61. GuruFocus rates LZAGY with a GF Score™ of 84/100 and a GF Value™ of $67.26 (Fairly Valued). The stock has 2 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Lonza Group ranks worse than 82.63% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Lonza Group's Enterprise Value is $51,345 Mil.
Lonza Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $1,853 Mil. Therefore, Lonza Group's EV-to-OCF for today is 27.71.
The historical rank and industry rank for Lonza Group's EV-to-OCF or its related term are showing as below:
LZAGY'
s EV-to-OCF Range Over the Past 10 Years
Min: 14.29 Med: 31.61 Max: 54.42
Current: 27.71
During the past 13 years, the highest EV-to-OCF of Lonza Group was 54.42. The lowest was 14.29. And the median was 31.61.
LZAGY's EV-to-OCF is ranked worse than 82.63% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 5.92
vs LZAGY: 27.71
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Lonza Group's PE Ratio (TTM) for today is calculated as:
Lonza Group's share price for today is $67.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.177.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Lonza Group EV-to-OCF Related Terms
Lonza Group EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Lonza Group's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Lonza Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lonza Group EV-to-OCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Lonza Group's EV-to-OCF falls into.
Lonza Group's current Enterprise Value is $51,345 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $1,853 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lonza Group (LZAGY) has a EV-to-OCF of 27.71 as of Sep. 22, 2026. This is 12% below median its historical median of 31.61. Over the past decade, Lonza Group's EV-to-OCF has ranged from 14.29 to 54.42. According to the industry distribution chart, Lonza Group ranks #176 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 82.6%.
Is Lonza Group's EV-to-OCF too high?
Lonza Group's current EV-to-OCF of 27.71 is 12% below median its 10-year median of 31.61. Over the past 10 years, this metric has ranged from a low of 14.29 to a high of 54.42. The Medical Diagnostics & Research industry median EV-to-OCF is 5.92. Lonza Group's value of 27.71 is 368.1% above this industry median. Based on the distribution chart, Lonza Group ranks #176 out of 213 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Lonza Group has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Lonza Group's EV-to-OCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Lonza Group ranks #176 out of 213 companies for EV-to-OCF. This places Lonza Group in the lower half of its industry. The industry median EV-to-OCF is 5.92. Lonza Group's value of 27.71 is 368.1% above this benchmark. Historically, Lonza Group's own EV-to-OCF has ranged from 14.29 to 54.42 over the past decade. While the company's 10-year median is 31.61 vs. the industry median of 5.92, Lonza Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Diagnostics & Research company?
The median EV-to-OCF among Medical Diagnostics & Research companies is 5.92, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lonza Group's current EV-to-OCF of 27.71 is 368.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median EV-to-OCF is 5.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lonza Group's current EV-to-OCF is 27.71, which is 12% below median its own 10-year median of 31.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lonza Group stock overvalued right now?
Based on GuruFocus' analysis, Lonza Group (LZAGY) is currently considered Fairly Valued. The stock's GF Value™ is $67.26, compared to a current price of $67.00 — trading 0.4% below its estimated fair value. The current EV-to-OCF is 27.71, which is 12% below median its 10-year median of 31.61 and 368.1% above the Medical Diagnostics & Research industry median of 5.92. Lonza Group's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Lonza Group (LZAGY), the current EV-to-OCF is 27.71 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lonza Group (LZAGY) Overvalued in 2026?
Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued.
The current stock price of $67.00 is trading 0.4% below its estimated GF Value™ of $67.26.
GuruFocus considers Lonza Group to be Fairly Valued.
Key valuation signals for LZAGY:
EV-to-OCF: 27.71 (12% below median its 10-year median of 31.61)
GF Value™: $67.26 vs. price of $67.00 (0.4% below fair value)
Industry Position: 368.1% above the Medical Diagnostics & Research median (#176 of 213)
No single metric tells the full story. See the LZAGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
84GF Score
Get the complete analysis for LZAGY
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LZAGY has been successfully added to your 
